1MA L,DELFORGE M, VAN DUPPEN V, et al. Circulating myeloid and lymphoid precursor dendritic cells are clonally involved in myelodysplastic syndromes[J].Leukemia, 2004,18:1451- 1456.
2MATTEO RIGOLIN G, HOWARD J, BUGGINS A, et al. Phenotypic and functional characteristics of monocyte-derived dendritic cells from patients with myelodysplastic syndromes [J].Br J Haematol, 1999, 107: 844-850.
3MICHEVA I, THANOPOULOU E, MICHALO- POULOU S, et al. Defective tumor necrosis factor alpha- induced maturation of monocyte-derived dendrit ic cells in patients with myelodysplastic syndromes[J]. Clin Immunol,2004,113:310-317.
4MICHEVA I, THANOPOULOU E, MICHALOPOULOU S, et al. Impaired generation of bone marrow CD34 derived dendritic cells with low peripheral blood subsets in patients with myelodysplastic syndrome[J]. Br J Haematol, 2004,126 : 806- 814.
5FLORES-FIGUEROA E, GUTIERREZ-ESPINDOLA G,MONTESINOS J J, et al. In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome[J]. Leuk Res, 2002, 26:677-686.
6KOOK H,ZENG W,CUIBIN C, et al. Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia[J]. Exp Hematol, 2001,29 : 1270 - 1277.
7STUCKI A, HAYFLICK J S, SANDMAIER B M, et al. Antibody engagement of intercellular adhesion mo lecular3 triggers apoptosis of normal and leukaemie myeloid marrow cells[J].Br J Haematol, 2000,108: 157-166.
8MATSUDA M,MAEDA Y. Establishment of a myelodysplastic syndrome(MDS)/secondary AML-derived T lymphoid cell line K2 MDS[J]. Leuk Res, 2000,24 : 103-108.
9MELENHORST J J, ENIAFE R, FOLLMANN D, et al. Molecular and flow cytometric characterization of the CD4 and CD8 T-cell repertoire in patients with myelodysplastie syndrome[J]. Br J Haematol, 2002, 119:97-105.
10MATSUTANI T, YOSHIOKA T, TSURUTA Y, et al. Determination of T-cell receptors of clonal CD8 positive T-cells in myelodysplastic syndrome with erythroid hypoplasia[J]. Leuk Res, 2003,27 : 305- 312.
4Raza A, Mundle SD, Shetty V, et al. Novel insight into the biology of myelodysplastic syndromes: excessive apoptosis and the rode of cytokines[ J ]. Inter J Hematol, 1996,63 : 265.
5Mufti GJ. Ineffective haemapoiesis and apoptosis in myelodysplastic syndromes[J]. Br J Hamatol, 1998,103:176.
6Rajapaksa R, Ginzton N, Rott LS, et al. Altered oncoprotein expression and apoptosis in myelodysplastic syndromes marrow cells[J]. Blood 1996,88:4275.
7Saitoh T, Murakami H, Uchiumi H, et al. Myelodysplastic syndromes with nephritic syndrome[J]. Am J Hematol, 1999,60: 200.
8Okada D, Uchiumi H, Saito I, et al. Relatiorship between immunological abnormallities and paroxysmal noctumal hemoglobinuria clones in myelodysplastic syndromes[ J ]. Blood, 2000,96:1490a.
9Kitagawa W, Saito I, Kuwata T, et al. Overexpression of tumor necrosis factor( TNF )-alpha and interferon(IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromes[J].Leukemia, 1997, 11:2049.
10Gersuk GM,Beckham C,Loken MR, et al. Arole for tumor factor-a,Fas,Fas-ligand in maroow failure associated with myelodysplastic syndromes[J].Br J Maematol, 1998.103:176.
2Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
3Bennett J M. World Health Organization classification of the acute leukemia and myelodysplastic syndrome[J]. Int J Hematol, 2000, 72:131.
8Kim SK, Welsh RM. Comprehensive early and lasting loss of memory CD8 T cells and functional memory during acute and per- sistent viral infections[J]. J Immunol, 2004,172(5) : 3139.
9Barber DL,Wherry EJ, Masopust D, et al. Restoring function in exhausted CD8 T cell s during chronic viral infection[J]. Nature, 2006,439 (7077) .. 682.
